Clinical review 166: Growth hormone receptor antagonists.
about
The glomerular podocyte as a target of growth hormone action: implications for the pathogenesis of diabetic nephropathyA crucial role of activin A-mediated growth hormone suppression in mouse and human heart failure.Use of Pegvisomant in acromegaly. An Italian Society of Endocrinology guidelineGrowth hormone signaling in human T47D breast cancer cells: potential role for a growth hormone receptor-prolactin receptor complexThe role of growth hormone-receptor antagonism in relation to acromegaly.Dynamic tests and basal values for defining active acromegaly.New insights into growth hormone receptor function and clinical implications.The management of the patient with acromegaly and headache: a still open clinical challenge.Evaluation of growth hormone (GH) action in mice: discovery of GH receptor antagonists and clinical indications.Delivery of therapeutic proteins.Properties of antibodies to a synthetic peptide representing an epitope shared by receptors of the type I cytokine family.Effect of rosiglitazone on serum IGF-I concentrations in uncontrolled acromegalic patients under conventional medical therapy: results from a pilot phase 2 study.Growth hormone affects gene expression and proliferation in human prostate cancer cells.Development and characterization of high affinity leptins and leptin antagonists.Effects of medical therapy on pituitary tumors.Effects of an S84E mutation of bovine growth hormone in transgenic mice.
P2860
Q33554471-0C2F75CC-0C73-422E-AE26-ABAC27A88ABCQ34116906-B869A124-E184-4DAA-84B6-E5141BD4AE2EQ34277844-E9FE11CE-4CFB-42E0-A875-928B05176798Q34712091-EDBB2138-C919-482F-8B5C-320C9F749C55Q35925517-AB47D749-48AE-412A-9F54-7CF98867A497Q36626485-8CC57C2C-777B-4D00-9FAA-36EEAA50CE17Q37064814-480164DA-C451-4B29-991F-BB28CD8F5E36Q37353632-8B838369-2CA1-49E1-B308-6FC8B79FCD1CQ37619460-2DC1325E-DAE1-473C-BB87-2DC557A09E30Q37668486-8626D3DE-F159-42AB-B79A-1735F58E75AFQ39403391-BE07194E-65F6-4E94-A3E3-8DDE75BF40EAQ39673688-CFE08F8F-802B-460E-947B-8503EF573D88Q39693482-883A5839-6AD0-4974-8997-4428A468F52EQ39811464-58709B3D-8819-445C-98BF-2945461B2E81Q46612818-616D8CE9-2479-4742-9280-6D3C2F45E44AQ46973436-11751B3D-47B9-43BF-880C-3B5D90610C60
P2860
Clinical review 166: Growth hormone receptor antagonists.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Clinical review 166: Growth hormone receptor antagonists.
@ast
Clinical review 166: Growth hormone receptor antagonists.
@en
type
label
Clinical review 166: Growth hormone receptor antagonists.
@ast
Clinical review 166: Growth hormone receptor antagonists.
@en
prefLabel
Clinical review 166: Growth hormone receptor antagonists.
@ast
Clinical review 166: Growth hormone receptor antagonists.
@en
P2093
P356
P1476
Clinical review 166: Growth hormone receptor antagonists.
@en
P2093
Aart Jan van der Lely
Alex F Muller
John J Kopchick
P304
P356
10.1210/JC.2002-022049
P407
P577
2004-04-01T00:00:00Z